National and Kapodistrian University of Athens
Γονιδιακή θεραπεία νόσων του κεντρικού νευρικού συστήματος
Abstract
dc:descriptionGene therapy is a novel tool for treating central nervous system diseases with unfavorable prognosis. Despite the promising results of multiple clinical studies, the limited distribution of gene delivery, the reduced expression of the therapeutic gene in the target organ, and the low therapeutic index of some regimens constitute major obstacles. In particular, viral vectors have particular shortcomings attributed to the increased risk of mutagenesis, triggering of a subsequent immune response, limited size of the therapeutic gene, and complexity of scaling production. Nanotechnology offer a safe gene delivery platform devoid of adverse effects associated with virus-based systems. However, to date only a few clinical studies have shown promising results using non-viral gene vectors. This phenomenon is due to the inability of such genes to be evenly distributed in the brain parenchyma and the low rate of gene transfer to the target cells. Important barriers to this process are the blood-brain barrier and the extracellular space, which prevent the accumulation and wide distribution of nanoparticles. Here we constructed synthetic non-viral vectors capable of penetrating and evenly distributing within the brain tissue allowing expression of therapeutic genes in a large number of cells. Administration of these vectors by convection-enhanced delivery into the parenchyma permits further dispersion of the synthetic carriers. We expanded this particular technique to synthesize brain penetrating gene vectors using state-of-the-art biodegradable polymers. Furthermore, we used these non-viral vectors for the effective intracranial administration of therapeutic plasmids against glioblastoma. These vectors widely distribute within the tumor, and thus allow for high levels of therapeutic transgene expression thus significantly improving the therapeutic effect in two aggressive glioblastoma models. Finally, by combining blood-brain barrier opening using focused ultrasound with systemically administered nanoparticles, we developed a non-invasive strategy to achieve safe, highly localized, strong and stable expression of transgenes in the central nervous system.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mastorakos, Panagiotis
- Μαστοράκος, Παναγιώτης
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42189